These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 29248304

  • 1. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
    Walsh PR, Johnson S, Brocklebank V, Salvatore J, Christian M, Kavanagh D.
    Am J Kidney Dis; 2018 Feb; 71(2):287-290. PubMed ID: 29248304
    [Abstract] [Full Text] [Related]

  • 2.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Noris M, Bresin E, Mele C, Remuzzi G.
    ; 1993 Feb. PubMed ID: 20301541
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK, Kıhtır HS, Goknar N, Ersoy M, Akcay N, Sevketoglu E.
    Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
    [Abstract] [Full Text] [Related]

  • 11. [Atypical HUS caused by complement-related abnormalities].
    Yoshida Y, Matsumoto M.
    Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Atypical Hemolytic Uremic Syndrome Associated with Complement Factor H Mutation and IgA Nephropathy: A Case Report Successfully Treated with Eculizumab.
    Nakamura H, Anayama M, Makino M, Makino Y, Tamura K, Nagasawa M.
    Nephron; 2018 Feb; 138(4):324-327. PubMed ID: 29241200
    [Abstract] [Full Text] [Related]

  • 15. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.
    Clin Exp Nephrol; 2019 Jan; 23(1):65-75. PubMed ID: 29959568
    [Abstract] [Full Text] [Related]

  • 16. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.
    Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
    [Abstract] [Full Text] [Related]

  • 17. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
    Sharma S, Pradhan M, Meyers KE, Le Palma K, Laskin BL.
    Clin Nephrol; 2015 Sep; 84(3):181-5. PubMed ID: 25816809
    [Abstract] [Full Text] [Related]

  • 18. Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.
    Fakhouri F, Fila M, Provôt F, Delmas Y, Barbet C, Châtelet V, Rafat C, Cailliez M, Hogan J, Servais A, Karras A, Makdassi R, Louillet F, Coindre JP, Rondeau E, Loirat C, Frémeaux-Bacchi V.
    Clin J Am Soc Nephrol; 2017 Jan 06; 12(1):50-59. PubMed ID: 27799617
    [Abstract] [Full Text] [Related]

  • 19. Blockade of the Terminal Complement Cascade Using Ravulizumab in a Pediatric Patient With Anti-complement Factor H Autoantibody-Associated aHUS: A Case Report and Literature Review.
    Wu X, Szarzanowicz A, Garba A, Schaefer B, Waz WR.
    Cureus; 2021 Nov 06; 13(11):e19476. PubMed ID: 34912617
    [Abstract] [Full Text] [Related]

  • 20. A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab.
    Schalk G, Kirschfink M, Wehling C, Gastoldi S, Bergmann C, Hoppe B, Weber LT.
    Pediatr Nephrol; 2015 Jun 06; 30(6):1039-42. PubMed ID: 25752761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.